Nuevocor

Singapore, Singapore · Founded 2020 · Privately Held (backing)

Operator of a biotechnology firm intended to develop gene therapies for the treatment of cardiovascular disease. Nuevocor is based in Singapore, Singapore and was founded in 2020. Its last reported valuation was $30.1 million in Nov 2022. It has raised $80.6 million.

Last reported valuation

$30.1M

Oct 2026

Priced at

—

Total raised

$80.6M

Last round

—

How much has Nuevocor raised?

$80.6Macross 0 recorded rounds

Free account

More of Nuevocor with a free account

·The complete investor list: 12 names
·Watch Nuevocor: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

Nuevocor investors

12 investors are on record for Nuevocor, including EDBI, SEEDS Capital, Highlight Capital and Kurma Partners.

For fundraisers

Raising for a company like Nuevocor?

12 investors have backed Nuevocor.

See all 12 investors →

Frequently asked about Nuevocor

How much has Nuevocor raised?: Nuevocor has raised $80.6M in total across 0 recorded funding rounds.